Table 2.
Drugs predicted to influence largest number of immune subset changes.
| Drug | Subset changes | Status | Drug class |
|---|---|---|---|
| Irinotecan | 60 | Approved | Topoisomerase inhibitor |
| Puromycin | 58 | Experimental | Aminonucleoside antibiotic |
| Deptropine | 55 | Approved | Anti-histamine |
| Tyrphostin AG-825 | 54 | Experimental | Tyrosine kinase inhibitor |
| 0175029-0000 | 54 | Experimental | Unknown |
| Daunorubicin | 54 | Approved | Anthracycline |
| Medrysone | 53 | Approved | Corticosteroid |
| Bepridil | 52 | Approved | Calcium channel blocker |
| Etacrynic acid | 52 | Approved | Loop diuretic |
| Alsterpaullone | 52 | Experimental | Cyclin-dependent kinase inhibitor |
| Primaquine | 51 | Approved | Aminoquinoline |
| Procaine | 50 | Approved | Local anesthetic |
| Gliclazide | 50 | Approved | Anti-diabetic |
| Cinchonine | 50 | Experimental | Alkaloid |
| Piperidolate | 50 | Approved | Anti-cholinergic |